Anemia. A case-based approach. David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017

Similar documents
Anemia (3).ms4.25.Oct.15 Hemolytic Anemia. Abdallah Abbadi

Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss

Anemia (3).ms Hemolytic Anemia. Abdallah Abbadi Feras Fararjeh

Evaluation of Anemia. Md. Shafiqul Bari Associate professor (Medicine) SOMC

General Characterisctics

Hematology: Challenging Cases with Your Participation COPYRIGHT

Platelet and WBC disorders

Approach to the abnormal CBC

New phase 2 Clinical Trial Enrolling Now

SESSION 1 Reactive cytopenia and dysplasia

2013 AAIM Pathology Workshop

Updates for your practice August 2013 TLALELETSO. HIV & Anemia. Continued on Page 2

Interpreting the CBC. Robert Miller PA Assistant Professor of Clinical Pediatrics and Family Medicine USC Keck School of Medicine Retired

3 Ruba hussein Dr. ahmad Dr. ahmad

MDS 101. What is bone marrow? Myelodysplastic Syndrome: Let s build a definition. Dysplastic? Syndrome? 5/22/2014. What does bone marrow do?

The Irony of Anemia How to interpret the CBC

New phase 2 Clinical Trial Enrolling Now

Does Morphology Matter in 2017

HAEMATOLOGICAL EVALUATION OF ANEMIA. Sitalakshmi S Professor and Head Department of Clinical Pathology St John s medical College, Bangalore

I. Definitions. V. Evaluation A. History B. Physical Exam C. Laboratory evaluation D. Bone marrow examination E. Specialty referrals

Dairion Gatot, Soegiarto Ganie, Savita Handayani. Divisi Hematologi & Onkologi Medik Departemen Ilmu Penyakit Dalam FK-USU/RS H.Adam Malik Medan 2009

HEMOLY L TIC AN A EMIA

Myelodysplastic Syndrome: Let s build a definition

Anemia 1: Fourth year Medical Students/ October/21/ 2015/ Abdallah Abbadi.MD.FRCP Professor

The function of the bone marrow. Living with Aplastic Anemia. A Case Study - I. Hypocellular bone marrow failure 5/14/2018

Acute haemolysis and appearance of PNH-like clones in patients with vitamin B12 deficiency and iron deficiency after iron dextran administration

Let`s go for the diagnosis! Yazeed Toukan, MD Pediatric Pulmonary Institute, Ruth Rappaport Children`s Hospital July 2016

Overview of Aplastic Anemia. Overview of Aplastic Anemia. Epidemiology of aplastic anemia. Normal hematopoiesis 10/6/2017

Paroxysmal Nocturnal Hemoglobinuria

Preferred Clinical Services for Leading Age Florida August 26-27, 2015

MDS: Who gets it and how is it diagnosed?

Examination Tests from Pathological Physiology. Pavel Maruna et al. Reviewed by: Prof. MUDr. Emanuel Nečas, DrSc. Prof. MUDr. Jaroslav Veselý, CSc.

Things to never miss in the office. Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC

Anemia In the Insurance Applicant What do the numbers mean?

Updates in the Management of Anemia in Cancer. Taylor M. Ortiz, MD May 19, 2017

Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure

CONCORD INTERNAL MEDICINE CHRONIC KIDNEY DISEASE PROTOCOL. Revised May 30, 2012

Borderline cytopenias. Dr Taku Sugai Consultant Haematologist

Living with PNH 7/3/2013. Paroxysmal Nocturnal Hemoglobinuria (PNH): A Chronic, Systemic, and Life- Threatening Disease

Cytopaenias in HIV. Dr Maresce Bizaare Specialist Physician Clinical Haematology Fellow IALCH

CHERYL KOVALSKI, DO FACOI NO DISCLOSURES ACOI BOARD REVIEW 2018

Warm Autoantibodies in a Patient with Hemophagocytic Lymphohistiocytosis: A Case Report

Extra Notes 3. Warm. In the core (center) of the body, where the temperature is 37 C.

2. Non- hemolytic anemias 3. Normocytic Normochromic Normocytic Normochromic Blood loss. (MCV<80 fl) (MCV fl) (MCV>100 fl)

Case # 1. RBC Loss. CASE #1 (Continued) Blood Loss Is the Most Common Cause of Anemia. AGA Definition of Occult Blood Loss

A 60 year old woman with altered mental status and thrombotic microangiopathy. Josh Veatch

The primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam:

Solving Medical Mysteries Deducing diagnoses from clues in the CBC. Donald S. Houston MD PhD FRCPC

Lisa B. Weissmann, MD

CASE 106. Pancytopenia in the setting of marrow hypoplasia, a PNH clone, and a DNMT3A mutation

APPROACHING TO PANCYTOPENIA

Hematologic changes in systemic diseases. Chittima Sirijerachai

(anemia) ก hemoglobin concentration, hematocrit deviation 1 1 ก hemoglobin, hematocrit mean corpuscular volume (MCV) 2

Deconstructing the CBC

Lisa B. Weissmann, MD

GOOD MORNING! Thursday, July Heidi Murphy, MD Leslie Carter-King, MD

Interpreting an Abnormal CBC

SOLIRIS (eculizumab) Slide # 1. How do we treat PNH?

Disclosures/COI. Cases in Hematopathology. Outline. Heme Path Findings Not to Miss. Normal Peripheral Smear 6/30/2016

Symptoms and Signs in Hematology (2)/ 2013

Blood Components & Indications for Transfusion. Neda Kalhor

Dr Anzo William Adiga

Clinical implications for decreased lymphocytes (lymphopenia) o Corticosteroid therapy, adrenocortical hyperfunction, stress, shock

Brrrr, It s Cold In Here

THE UNIVERSITY OF JORDAN FACULTY OF MEDICINE DEPARTMENT OF PATHOLOGY

Approach to the child with anemia. Nittaya Wisanuyothin,MD. Pediatrics Department, Maharat Nakhonratchasima Hospital

Polycthemia Vera (Rubra)

Bor-Sheng Ko. Hematology Division, Department of Internal Medicine, National Taiwan University Hospital

PATTERNS TO EASILY IDENTIFY AND TESTING TO EFFECTIVELY CONFIRM

Polycythemia Vera and other Myeloproliferative Neoplasms. A.Mousavi

Challenges in the Laboratory Diagnosis of Anemia

The Complete Blood Count

74y old Female with chronic elevation of Platelet count. August 18, 2005 Faizi Ali, MD Hematopathology Fellow

5/5/2010. Goldilocks picture from

Evaluation of the Inpatient with Anemia

Evaluation of the Inpatient with Anemia

The University of Mississippi Medical Center The University of Mississippi Health Care. Pharmacy and Therapeutics Committee Medication Use Evaluation

UNUSUAL PRESENTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS

Faculty of Medicine Dr. Tariq Aladily

Case Workshop of Society for Hematopathology and European Association for Haematopathology

Aplastic Anemia: Understanding your Disease and Treatment Options

11. An acute leukemia causing. 12. An adult patient presents with acute. 13. Anemia due to renal failure may be

INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS TABLE OF RECOMMENDED TESTS. Type of Reaction Presentation Recommended Tests Follow-up Tests

Aplastic anamia & Sideroblastic anemia

Diagnostic Approach to Patients with Anemia

Disorders of Blood Cells & Blood Coagulation

Approach to a pale child

Latest updates in Myeloproliferative Neoplasms. Elizabeth Hexner, MD, MSTR

Anemia. Tong Chen Department of Hematology Huashan Hospital

Pathophysiology 7/18/2012 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

When Selfies Go Bad!

Aplastic Anemia. is a bone marrow failure disease 9/19/2017. What you need to know about. The 4 major components of blood

MORPHOLOGY IN ACTION. Description MINI-CASE ONE OBJECTIVES. Differential Diagnosis. Laboratory Results

HOVON 141 CLL. Version 3, 25JUL2018. Table Required investigations at entry, during treatment and during follow up.

Investigation and Management of Chronic Lymphocytic Leukemia. James Johnston

Myelodysplastic Syndromes: Everyday Challenges and Pitfalls

Management of anemia in CKD

ASPEN MOUNTAIN MEDICAL CENTER. Lab Health Fair

Transcription:

Anemia A case-based approach David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017

Recognizing trends Learning Objectives MCV, RDW, Ferritin, LDH, Reticulocytes Managing complex patients 1. When to do nothing 2. When to watch 3. When to test 4. When to refer 2

Ask Google about anemia 3

Anemia Symptoms 4

When does anemia lead to fatigue? 27% 45% Hematocrit 5

6

67M with erythrocytosis

67M with erythrocytosis WBC HGB HCT MCV PLT DEC 9.9 19.0 59.2 86 358 He feels great Incidentally discovered on routine labs at physical Vitals: HR 65, BP 122/76, O 2 sat 98% PMH: Hypertension (controlled) 8

67M with erythrocytosis A. Recheck CBC in 3 months B. Send a serum erythropoietin C. Send him for a sleep study D. Send him for an echocardiogram E. Send iron studies (Ferritin, Fe, TIBC) 9

Erythrocytosis Evaluation http://www.mayomedicallaboratories.com/ 10

EPO 1.1 (normal 4-20) Highly suppressed Lab Results JAK2V617F POSITIVE A JAK2 mutation is pathognomonic for a myeloproliferative neoplasm ~99% of polycythemia vera ~50% of essential thrombocythemia 11

67M with JAK2+ Polycythemia Vera A. Follow until HCT > 60% B. ASA C. ASA + therapeutic phlebotomy to goal HCT<45% D. ASA + hydrea to goal HCT<45% E. ASA + bone marrow transplant evaluation 12

He comes back to see me in 2 months WBC HGB HCT MCV PLT DEC 9.9 19.0 59.2 86 358 FEB 3.8 10.9 33.0 132 234 Why is the MCV so high!? 13

Now on a stable dose of hydrea WBC HGB HCT MCV PLT DEC 9.9 19.0 59.2 86 358 FEB 3.8 10.9 33.0 132 234 APR 6.0 14.0 43.3 118 270 Remember: Polycythemia Vera is a clonal stem cell disorder, thus affecting all lineages 14

65F with anemia

65F with anemia 16

65F with anemia A. Looks like iron deficiency B. Looks like B12 deficiency C. Looks like chronic kidney disease D. Why is the RDW so wide? E. We need some more labs 17

65F with anemia CREAT 1.1 BILI 0.1 LDH 282 (normal up to 200) FERRITIN 160 FE 35, TIBC 253 B12 normal FOLATE normal EPO 27 (normal range 3-19) Serum protein electrophoresis: normal 18

The trend in the MCV 08/2015 03/2017 19

65F with anemia and increasing MCV A. Worsening liver disease B. Started a new medication (e.g. methotrexate) C. Drinking more (e.g. toxic effects of alcohol) D. Worsening renal disease despite normal creatinine E. MDS needs a bone marrow biopsy 20

Each of us has our own MCV baseline Normocytic is relative to the individual patient Even modest alcohol, especially in older patients, can lead to macrocytosis without anemia 90 86 2011 2017 21

34M with a cold

34M with a cold Young child in daycare : I caught a cold Felt better, but never quite fully recovered Wife said that he looked a little yellow last week Now in the ED with my heart is racing WBC 7.4, HCT 17.2, MCV 87, PLT 184 BILIRUBIN TOTAL 1.5, DIRECT 0.4 LDH 684 23

34M with a cold A. Needs a bone marrow biopsy B. Needs a PT, PTT, and Fibrinogen C. Needs a haptoglobin checked D. Expect to see schistocytes on the smear E. Expect to see spherocytes on the smear 24

Autoimmune hemolytic anemia BM: would show erythroid hyperplasia PT, PTT, Fibrinogen: should be normal Haptoglobin: would expect it to be low Schistocytes: NO. Spherocytes: YES. 25

AIHA A. Start steroids. B. Start steroids and IVIG. C. Check mycoplasma IgG and IgM. D. Send a Coombs test (direct antiglobulin test). E. Check HIV. 26

AIHA DAT + : IgG Warm autoantibody IgG Usually idiopathic Can be associated with a lymphoproliferative disease Steroids DAT + : Complement Cold autoantibody IgM Often associated with a mycoplasma infection Self-limited, steroids generally are not helpful 27

Trends: LFTs, LDH, WBC, MCV, NRBC, RETIC 3/10 3/3 2/17 2/10 2/1 1/31 1/30 1/29 1/28 1/27 1/25 ALT 19 21 52 348 511 586 680 380 321 321 427 AST 19 18 33 56 94 113 201 118 94 94 84 ALKP 66 66 77 133 126 133 155 133 135 135 153 TBILI 0.7 0.8 1 1.2 0.7 0.9 1.2 1.3 1.8 1.8 1.5 DBILI <0.2 <0.2 <0.2 0.3 0.3 0.4 0.4 0.4 LDH 206 234 290 246 373 415 467 844 813 684 WBC 4.35 4.83 6.17 8.07 4.9 6.24 6.55 8.94 10.29 20.01 30.23 HGB 11.4 11.1 11.3 10.7 8.5 8.6 8 8.2 9.6 5.2 6.1 HCT 32.4 31.2 33.3 32.6 27.5 27.1 24.7 24.4 28.8 15.4 17.2 MCV 86.2 87.4 94.3 100.9 102.6 100.7 99.2 95.3 93.8 89 85.6 PLT 172 214 246 165 112 96 97 110 137 142 184 RDW 13.8 14.1 15.6 22.6 24.9 25.1 23.6 20.7 19.8 16.9 16.2 NRBC% 0 0 0 0 1.2 1.3 2.2 3.6 5.4 8.7 7 RETIC 4.1 5.5 5.4 >23.0 >23.0 23 17.4 10.1 5.6 3.8 28

A little aside on EPO

Erythropoietin Produced in specialized fibroblasts in the kidney Highly responsive to hypoxia Normal range is usually 4-20 30

1000 100 10 31

HGB=15 HCT=45% EPO=10 32

HGB=9 HCT=27% EPO=100 33

HGB=6 HCT=18% EPO=1000 34

What suppresses EPO production? Pretty much everything. Age Renal disease Illness Inflammation Cancer Take care when interpreting an EPO result in a hospitalized patient 35

So when is the serum EPO useful? Helpful in the outpatient setting when one is wondering what the contribution of low EPO production is having on the HGB/HCT 81F with CREAT 0.9 and HGB 9.5, HCT 28%, MCV 89 EPO should be 50-100 If the EPO comes back at 19, though it will be flagged in the normal range, the EPO is actually low given the degree of anemia 36

45M with thrombocytopenia

45M with thrombocytopenia 38

45M with thrombocytopenia A. Probably a transient viral process. B. Probably a medication side-effect. C. Probably ITP (immune thrombocytopenic purpura). D. Probably Aplastic Anemia. E. Probably MDS. F. Probably Acute Leukemia (AML or ALL). 39

Context: 45M with thrombocytopenia 45M Time course seems to be going on for a few weeks Concerns: All three lines are low ANC is down Red herrings? Exposures in India 40

45M with thrombocytopenia 2-weeks later 41

What do we need for work-up? A. HIV, HBC, HCV, CMV, EBV testing. B. Peripheral blood flow cytometry for PNH. C. Coombs test, LDH, Reticulocyte count. D. Bone marrow biopsy. E. Trial of steroids +/- IVIG. 42

A D are all correct Suspect aplastic anemia Aplastic anemia is caused by a toxic or autoimmune attack on the hematopoietic stem cell It leads to pancytopenia because of underproduction LDH is typically LOW RETIC is typically <0.5% Rule out destructive processes 43

74M with diarrhea and weight loss

74M with diarrhea and weight loss CREAT 0.9 BILI 0.6 LDH 260 RETIC 2.4% ALBUMIN 2.9 HIV+ on Rx, suppressed VL and normal CD4 BMI 16 45

Anemia is caused by A. Low level of HIV despite treatment B. Co-infection with Hepatitis C C. TTP: Thrombotic Thrombocytopenia Purpura D. Lymphoma infiltration of the bone marrow E. Severe malnutrition 46

David BMI 16. Albumin 2.9. Prealbumin 9. Patient 47

Marrow aplasia Bone marrow biopsy: <5% cellularity Gelatinous transformation of the bone marrow Seen in cases of AIDS Severe protein malnutrition Anorexia 48

56F with anemia and a rejected CBC 49

56F with anemia 50

56F with anemia

What is going on? A. Warm autoimmune hemolytic anemia. B. Paroxysmal Nocturnal Hemoglobinuria. C. Drug-induced hemolytic anemia. D. Cryoglobulinemia. E. Cold agglutinin disease. 52

56F with anemia

56F with anemia

56F with anemia

How do you treat cold-agglutinins? A. Steroids. B. IVIG. C. Cytoxan. D. Rituximab. E. Rituximab and Fludarabine. 59

An intriguing and practical paper on iron absorption 61

Recommended daily iron 62

Hypothesis: supplemental iron downregulates the body s ability to absorb the next dose of iron Blood. Volume 126(17):1981-1989. October 22, 2015

Iron dose vs. Iron absorbed

Iron dose vs. Iron absorbed AM Dose PM Dose

Feosol Original Ferrous Sulfate 325 mg 20% elemental iron Elemental Fe 65 mg 66

Feosol Natural Release Carbonyl iron 100% elemental iron Elemental Fe 45 mg 67

Feosol Complete Iron polysaccharide + Heme iron polypeptide Elemental Fe 28 mg 68

Ferrous Gluconate Fe Gluconate 240 mg 12% elemental iron Elemental Fe 28 mg 69

Ferrous Fumarate Fe Fumarate 54 mg 33% elemental iron Elemental Fe 18 mg 70

MegaFood Blood Builder 71

So then what to tell our patients? Many of the side effects of iron can be avoided by trying a lower dose formulation Much of the benefit of iron supplementation can be derived from taking them every-other-day I like to start patients on a MON/WED/FRI schedule and see how they do iron of their choice. 72

73